List of Tables
Table 1. Global Major Depressive Disorder Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Major Depressive Disorder Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Major Depressive Disorder Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Major Depressive Disorder Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Major Depressive Disorder Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Major Depressive Disorder Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Major Depressive Disorder Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Major Depressive Disorder Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Major Depressive Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Major Depressive Disorder Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Major Depressive Disorder Drug, Product Type & Application
Table 12. Global Key Manufacturers of Major Depressive Disorder Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Major Depressive Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Major Depressive Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Major Depressive Disorder Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Major Depressive Disorder Drug Sales Market Share by Region (2020-2025)
Table 19. Global Major Depressive Disorder Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Major Depressive Disorder Drug Sales Market Share by Region (2026-2031)
Table 21. Global Major Depressive Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Major Depressive Disorder Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Major Depressive Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Major Depressive Disorder Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Major Depressive Disorder Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Major Depressive Disorder Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Major Depressive Disorder Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Major Depressive Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Major Depressive Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Major Depressive Disorder Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Major Depressive Disorder Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Major Depressive Disorder Drug Sales Market Share by Type (2020-2025)
Table 53. Global Major Depressive Disorder Drug Sales Market Share by Type (2026-2031)
Table 54. Global Major Depressive Disorder Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Major Depressive Disorder Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Major Depressive Disorder Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Major Depressive Disorder Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Major Depressive Disorder Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Major Depressive Disorder Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Major Depressive Disorder Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Major Depressive Disorder Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Table 63. Global Major Depressive Disorder Drug Sales Market Share by Application (2026-2031)
Table 64. Global Major Depressive Disorder Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Major Depressive Disorder Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Major Depressive Disorder Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Major Depressive Disorder Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Major Depressive Disorder Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Major Depressive Disorder Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Bristol-Myers Squibb Company Company Information
Table 71. Bristol-Myers Squibb Company Description and Business Overview
Table 72. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product
Table 74. Bristol-Myers Squibb Company Recent Developments/Updates
Table 75. Cerecor Inc. Company Information
Table 76. Cerecor Inc. Description and Business Overview
Table 77. Cerecor Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Cerecor Inc. Major Depressive Disorder Drug Product
Table 79. Cerecor Inc. Recent Developments/Updates
Table 80. e-Therapeutics Plc Company Information
Table 81. e-Therapeutics Plc Description and Business Overview
Table 82. e-Therapeutics Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. e-Therapeutics Plc Major Depressive Disorder Drug Product
Table 84. e-Therapeutics Plc Recent Developments/Updates
Table 85. Eli Lilly and Company Company Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Eli Lilly and Company Major Depressive Disorder Drug Product
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd. Company Information
Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product
Table 94. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 95. GlaxoSmithKline Plc Company Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Plc Major Depressive Disorder Drug Product
Table 99. GlaxoSmithKline Plc Recent Developments/Updates
Table 100. H. Lundbeck A/S Company Information
Table 101. H. Lundbeck A/S Description and Business Overview
Table 102. H. Lundbeck A/S Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. H. Lundbeck A/S Major Depressive Disorder Drug Product
Table 104. H. Lundbeck A/S Recent Developments/Updates
Table 105. Hua Medicine Ltd. Company Information
Table 106. Hua Medicine Ltd. Description and Business Overview
Table 107. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Hua Medicine Ltd. Major Depressive Disorder Drug Product
Table 109. Hua Medicine Ltd. Recent Developments/Updates
Table 110. Intra-Cellular Therapies, Inc. Company Information
Table 111. Intra-Cellular Therapies, Inc. Description and Business Overview
Table 112. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product
Table 114. Intra-Cellular Therapies, Inc. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Major Depressive Disorder Drug Distributors List
Table 118. Major Depressive Disorder Drug Customers List
Table 119. Major Depressive Disorder Drug Market Trends
Table 120. Major Depressive Disorder Drug Market Drivers
Table 121. Major Depressive Disorder Drug Market Challenges
Table 122. Major Depressive Disorder Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Major Depressive Disorder Drug
Figure 2. Global Major Depressive Disorder Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Major Depressive Disorder Drug Market Share by Type: 2024 & 2031
Figure 4. Aripiprazole Product Picture
Figure 5. AV-101 Product Picture
Figure 6. AVP-786 Product Picture
Figure 7. Basimglurant Product Picture
Figure 8. Brexpiprazole Product Picture
Figure 9. Others Product Picture
Figure 10. Global Major Depressive Disorder Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Major Depressive Disorder Drug Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Research Center
Figure 15. Global Major Depressive Disorder Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Major Depressive Disorder Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Major Depressive Disorder Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Major Depressive Disorder Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Major Depressive Disorder Drug Report Years Considered
Figure 20. Major Depressive Disorder Drug Sales Share by Manufacturers in 2024
Figure 21. Global Major Depressive Disorder Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Major Depressive Disorder Drug Players: Market Share by Revenue in Major Depressive Disorder Drug in 2024
Figure 23. Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Major Depressive Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Major Depressive Disorder Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Major Depressive Disorder Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. U.A.E Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Major Depressive Disorder Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Major Depressive Disorder Drug by Type (2020-2031)
Figure 60. Global Major Depressive Disorder Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Major Depressive Disorder Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Major Depressive Disorder Drug by Application (2020-2031)
Figure 63. Global Major Depressive Disorder Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Major Depressive Disorder Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
